Valuation : Zynex, Inc.

Market Cap 3.83M 3.29M 3.1M 2.83M 5.29M 364M 5.31M 36.77M 14.21M 186M 14.38M 14.07M 588M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 32.72M 30.81M 28.07M 52.52M 3.62B 52.73M 365M 141M 1.84B 143M 140M 5.84B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-8.33%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.1
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 17/08/2025
Director of Finance/CFO 50 17/08/2025
General Counsel 53 17/08/2025
Director TitleAgeSince
Director/Board Member 50 25/03/2026
Director/Board Member 53 25/03/2026
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/26 Issuer sale

Director

80,001 0.2633%
26/03/26 Issuer sale

Director

95,000 0.3126%
26/03/26 Issuer sale

Director

102,000 0.3357%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-96.33%-99.26% 1.69M
+0.44%-0.47%+25.56%+16.87% 224B
-0.19%-2.41%+5.41%-17.52% 144B
+0.88%-5.01%-24.45%+18.45% 125B
-0.04%-7.05%-58.41%-16.54% 65.16B
-0.79%-1.95%-18.10%-13.39% 50.05B
-0.62%-5.11%+7.99%+16.35% 49.67B
-1.43%-4.39%+14.65%+26.98% 40.81B
+0.47%-1.79%+34.70%+53.59% 39.77B
-2.87%-3.87%+108.72%+29.45% 30.96B
Average +0.16%-4.52%-0.02%+1.50% 76.92B
Weighted average by Cap. -0.03%-2.29%+5.83%+8.80%

Financials

2023 2024
Net sales 184M 159M 149M 136M 255M 17.54B 256M 1.77B 684M 8.94B 692M 677M 28.31B 192M 166M 156M 142M 266M 18.3B 267M 1.85B 714M 9.32B 722M 707M 29.54B
Net income 9.73M 8.37M 7.89M 7.18M 13.44M 926M 13.5M 93.45M 36.12M 472M 36.54M 35.75M 1.49B 2.99M 2.58M 2.43M 2.21M 4.14M 285M 4.15M 28.75M 11.11M 145M 11.24M 11M 460M
Net Debt 31.59M 27.18M 25.59M 23.32M 43.63M 3.01B 43.81M 303M 117M 1.53B 119M 116M 4.85B 34.19M 29.42M 27.7M 25.24M 47.23M 3.25B 47.42M 328M 127M 1.66B 128M 126M 5.25B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!